GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Market Cap

YIFAN PHARMACEUTICAL CO (SZSE:002019) Market Cap : ¥16,637 Mil (As of May. 26, 2024)


View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). YIFAN PHARMACEUTICAL CO's share price for the quarter that ended in Mar. 2024 was ¥11.08. YIFAN PHARMACEUTICAL CO's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 1,226 Mil. Therefore, YIFAN PHARMACEUTICAL CO's market cap for the quarter that ended in Mar. 2024 was ¥13,584 Mil.

YIFAN PHARMACEUTICAL CO's quarterly market cap increased from Sep. 2023 (¥16,809 Mil) to Dec. 2023 (¥18,121 Mil) but then declined from Dec. 2023 (¥18,121 Mil) to Mar. 2024 (¥13,584 Mil).

YIFAN PHARMACEUTICAL CO's annual market cap declined from Dec. 2021 (¥21,745 Mil) to Dec. 2022 (¥15,019 Mil) but then increased from Dec. 2022 (¥15,019 Mil) to Dec. 2023 (¥18,121 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. YIFAN PHARMACEUTICAL CO's Enterprise Value for Today is ¥17,814 Mil.


YIFAN PHARMACEUTICAL CO Market Cap Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Market Cap Chart

YIFAN PHARMACEUTICAL CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20,099.63 23,372.49 21,745.02 15,018.75 18,120.58

YIFAN PHARMACEUTICAL CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,213.32 17,899.89 16,808.73 18,120.58 13,584.30

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Market Cap

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YIFAN PHARMACEUTICAL CO's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Market Cap distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Market Cap falls into.



YIFAN PHARMACEUTICAL CO Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

YIFAN PHARMACEUTICAL CO's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥14.78*1226.02
=¥18,121

YIFAN PHARMACEUTICAL CO's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥11.08*1226.02
=¥13,584

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


YIFAN PHARMACEUTICAL CO  (SZSE:002019) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


YIFAN PHARMACEUTICAL CO Market Cap Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.
Executives
Ye Yi Qun Director
Zhang Da Wei Executives
Geng Yu Hong Executives
Feng De Qi Directors, Directors, and Executives
Zhou Ben Yu Director
Lin Xing Directors, executives
Yu Hai Xia Executives
Cheng Xian Feng Directors, executives
Xu Guo Han Supervisors
Cao Shi Mei Director
Lin Guan Yu Director
Zhang Lian Chun Executives
Guo Xin Fu Director
Zheng Shi Ming Supervisors
Yin Hang Hua Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines